White G H, Yu W, May J, Waugh R, Chaufour X, Harris J P, Stephen M S
Department of Vascular Surgery, Royal Prince Alfred Hospital, University of Sydney, Australia.
J Endovasc Surg. 1997 May;4(2):124-36. doi: 10.1583/1074-6218(1997)004<0124:TYEWTW>2.0.CO;2.
To report a > 3-year experience with a modular, balloon-expandable endovascular graft used for aneurysm exclusion in the aorta and other arteries.
The customized White-Yu Endovascular GAD Graft, a woven polyester prosthesis with an intrinsic Elgiloy wire graft attachment system along the body of the graft, is a flexible endograft design available in straight, tapered, and bifurcated versions that can be delivered transluminally through 18F to 24F sheaths.
Since July 1993, 93 patients have received the White-Yu endograft for treatment of 76 abdominal aortic, 3 thoracic aortic, 13 iliac, and 1 popliteal aneurysms. Of the 79 aortic procedures, 39 involved straight tube grafts, 20 were tapered aortoiliac models, and 20 were bifurcated devices. Success rates for tube grafts were 81% in the abdominal aorta and 100% for the thoracic aorta; 5 primary endoleaks (14%) and 2 conversions to surgery (5.6%) occurred with this graft type. Aortoiliac grafts were deployed successfully in 95% (19/20) of cases with 1 conversion (5%) due to thrombosis. Seventy-five percent of the bifurcated endograft procedures were successful, with 4 conversions (20%) for technical failures and 1 graft thrombosis. Four additional endografts were deployed to treat two primary and two secondary endoleaks in tube graft patients. Two access-related arterial injuries were treated surgically. There was one case of embolus to the distal femoral artery but no microembolization. Overall perioperative (30-day) mortality was 3.1%. Over a mean 18-month follow-up (range 2 to 39), no late graft thrombosis, stenosis, or graft migration has been seen on CT scans or X ray. Endoleak has not been detected in any aortoiliac or bifurcated graft. Aneurysm size has diminished consistently in successfully treated cases.
The White-Yu endograft appears to offer a safe, efficacious, and minimally invasive means of excluding aneurysms from the circulation. Improvements in patient selection, surgical techniques, and equipment have reduced the incidence of endoleak and conversion to open repair over the course of the evaluation.
报告使用模块化球囊扩张式血管内移植物排除主动脉和其他动脉动脉瘤超过3年的经验。
定制的White-Yu血管内GAD移植物是一种编织聚酯假体,沿移植物主体具有固有的埃尔吉洛伊丝(Elgiloy)金属丝移植物附着系统,是一种灵活的腔内移植物设计,有直管、锥管和分叉型,可通过18F至24F鞘管经腔输送。
自1993年7月以来,93例患者接受了White-Yu腔内移植物治疗,其中腹主动脉瘤76例、胸主动脉瘤3例、髂动脉瘤13例、腘动脉瘤1例。在79例主动脉手术中,39例使用直管移植物,20例使用锥管型主髂动脉移植物,20例使用分叉型装置。直管移植物在腹主动脉的成功率为81%,在胸主动脉为100%;该移植物类型发生5例原发性内漏(14%)和2例转为手术治疗(5.6%)。主髂动脉移植物在95%(19/20)的病例中成功植入,1例(5%)因血栓形成而转为手术。分叉型腔内移植物手术75%成功,4例(20%)因技术失败而转为手术,1例移植物血栓形成。另外植入4个腔内移植物治疗直管移植物患者的2例原发性和2例继发性内漏。2例与穿刺相关的动脉损伤接受了手术治疗。有1例股动脉远端栓塞,但无微栓塞。围手术期(30天)总体死亡率为3.1%。平均随访18个月(范围2至39个月),CT扫描或X线检查未发现晚期移植物血栓形成、狭窄或移植物移位。在任何主髂动脉或分叉型移植物中均未检测到内漏。在成功治疗的病例中,动脉瘤大小持续缩小。
White-Yu腔内移植物似乎提供了一种安全、有效且微创的方法,可将动脉瘤排除在血液循环之外。在评估过程中,患者选择、手术技术和设备的改进降低了内漏和转为开放修复的发生率。